RECRUITINGOBSERVATIONAL
Development of New Personalised 3D Preclinical Models of Pancreatic Neuroendocrine Tumours
About This Trial
The goal of this prospective observational study is to generate new personalised 3D preclinical models of pancreatic neuroendocrine tumors. The models will be exploited for studying the mechanisms underlying disease development and progression, as well as for performing drug testing. For the development of the newly proposed models, patients' surgical specimens will be evaluated by the Pathological Unit. If the presence of pathological material in excess, not required for the routine diagnostic procedure, is confirmed, such material will be employed for the generation of the proposed personalised models.
Who May Be Eligible (Plain English)
Who May Qualify:
- patients who undergo pancreatic surgical resection for non-functioning pancreatic neuroendocrine tumor
- age ≥ 18 years
- willing to sign a consent form
Who Should NOT Join This Trial:
- non-pancreatic neuroendocrine tumor histological diagnosis
- age \< 18 years
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion criteria:
* patients who undergo pancreatic surgical resection for non-functioning pancreatic neuroendocrine tumor
* age ≥ 18 years
* informed consent
Exclusion criteria:
* non-pancreatic neuroendocrine tumor histological diagnosis
* age \< 18 years
Locations (1)
IRCCS San Raffele Institute
Milan, MI, Italy